Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review
Purpose: Livedoid vasculopathy (LV) is a chronic microvascular thrombosis disorder with an unclear pathogenesis, potentially involving hypercoagulability and inflammation. This systematic review aims to evaluate the efficacy and safety of Janus kinase (JAK) inhibitors and biologics in the treatment...
Saved in:
| Main Authors: | Yu Liu, Tingting Li, Wei Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2451804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Livedoid Vasculopathy Successfully Treated With JAK Inhibitors
by: Antoine Delpuech, et al.
Published: (2025-06-01) -
Effective Treatment of Livedoid Vasculopathy With Oral Tofacitinib
by: Parvin Mansouri, et al.
Published: (2025-06-01) -
Successful healing of a chronic ulcer in livedoid vasculopathy using PuraPly: A case report
by: Sofia Angel, BS, et al.
Published: (2025-09-01) -
Baricitinib Successfully Treated a Teenager with Refractory Livedoid Vasculopathy: A Case Report and Literature Review
by: Liu C, et al.
Published: (2025-02-01) -
A case report and literature review of livedoid vasculopathy in children
by: Jing Qu, et al.
Published: (2025-05-01)